Related Experiment Video
Updated: Sep 28, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
RNA-binding proteins in diabetic microangiopathy.
Chao Tu1, Liangzhi Wang1, Lan Wei1
1Department of Internal Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
RNA binding proteins (RBPs) are key players in diabetic microangiopathy, impacting diabetic retinopathy and nephropathy. Research shows RBPs offer potential as therapeutic targets and diagnostic markers for these diabetes complications.
Area of Science:
- Molecular Biology
- Endocrinology
- Ophthalmology
Background:
- Diabetic microangiopathy, encompassing diabetic retinopathy (DR) and nephropathy (DN), is a major complication of diabetes.
- RNA binding proteins (RBPs) are crucial for cellular processes and implicated in diabetes pathogenesis.
Purpose of the Study:
- To review the role of RBPs in diabetic retinopathy and nephropathy.
- To explore the therapeutic and diagnostic potential of RBPs in diabetic microangiopathy.
Main Methods:
- Literature review of studies on RBPs in diabetic microangiopathy.
- Analysis of RBP involvement in DR and DN pathogenesis and progression.
Main Results:
- RBPs demonstrate potential as therapeutic targets, diagnostic markers, and predictors of disease progression in diabetic microangiopathy.
- Specific RBPs like HuR are highlighted for their therapeutic potential in diabetic microangiopathy.
Conclusions:
- HuR is a vital therapeutic target for diabetic microangiopathy.
- IGF2BP2, P311, TTP, YBX1, and MBNL1 show promise for treating diabetic nephropathy (DN).
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: The Receptor and Signaling Pathways

